Gaster et al in “Annual Reports in Medicinal Chemistry”, vol. 33. pp. 21-30 (1998).* |
K.-E. Andersson, “Pharmacology of Penile Erection”, Pharmacological Reviews, vol. 53, No. 3, pp. 417-450 (2001). |
Anibal A. Arjona et al., “Effect of a 5-HT2c serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs”, Brain Research, 951, pp. 135-140 (2002). |
M. Bancila et al., “5-Hydroxytryptamine2c Receptors on Spinal Neurons Controlling Penile Erection in the Rat”, Neuroscience, vol. 92, No. 4, pp. 1523-1537 (1999). |
Mike J. Bickerdike et al., “5-HT2c receptor modulation and the treatment of obesity”, Diabetes, Obesity and Metabolism, pp. 207-214 (1999). |
Ewa Chojnacka-Wójcik et al., “Involvement of 5-HT2c Receptors in the m-CPP-Induced Antinociception in Mice”, Pol. J. Pharmacol., vol. 46, pp. 423-428 (1994). |
Florence Clenet et al., “Involvement of 5-HT2c receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice”, European Neuropsychopharmacology, vol. 11, pp. 145-152 (2001). |
John F. Cryan et al., “Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2c Receptors1” The Journal of Pharmacology and Experimental Therapeutics, vol. 295, No. 3, pp. 1120-1126 (2000). |
S.N. E{haeck over (g)}e, “The Chemistry of hererocyclic Compounds” Organic Chemistry, pp 1009-1011 (1984). |
Lawrence W. Fitzgerald et al., “Chapter 3: 5-HT2c Receptor Modulators: Progress in Development of New CNS Medicines”, Annual Reports in Medicinal Chemistry, vol. 37, pp. 21-30 (2002). |
Laramie M. Gaster et al., “Chapter 3. Latest Developments in Serotonin Receptor Modulation”, Annual Reports in Medicinal Chemistry, vol. 33, pp. 21-30 (1998). |
Goodman and Gilman's, “Biotransformation of Drugs” The Pharmacological Basis of Therapeutics, 8th ed., McGraw-Hill, Int. Ed. 1992, p. 13-18. |
A.J. Grottick et al., “Activation of 5-HT2c receptors reduces the locomotor and rewarding effects of nicotine”, Psychopharmacology, vol. 157, pp. 292-298 (2001). |
Andrew J. Grottick et al., “Studies to Investigate the Role of 5-HT2c Receptors on Cocaine-and Food-Maintained Behavior1”, The Journal of Pharmacology and Experimental Therapeutics, vol. 295, No. 3, pp. 1183-1191 (2000). |
L. Guarneri et al., “The Effects of mCPP and Bladder voiding contractions in Rats are Mediated by the 5-HT2A/5-HT2c Receptors”, Neurourol.Urodyn, vol. 15, pp. 316-317 (1996). |
John A. Harvey, “Serotonergic regulation of associative learning”, Behavioural Brain Research, vol. 73, pp. 47-50 (1996). |
Thomas F. Murray et al., “A comparison of the Analgesic Activities of 4,5,6,7-Tetrahydroisoxazolo[5,4-c] Pyridin-3-ol (Thip) and 6-Chloro-2[1-Piperazinyl] Pyrazine (MK 212)”, European Journal of Pharmacology, vol. 90, pp. 179-184 (1983). |
Roger M. Nitsch et al., “Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodormain Secretion”, The Journal of Biological Chemistry, vol. 271, No. 8, pp. 4188-4194 (1996). |
M.J. Piesla et al., “Atypical Antipsychotic-Like Effects of 5-HT2C Agonists”, Schizophrenia Research, 49 (1-2), 95. Sp. Iss. SI Suppl. S Apr. 15, 2001. |
Beatriz A. Rocha et al., “Enhanced Locomotor, Reinforcing, and Neurochemical Effects of Cocaine in Serotonin 5-Hydroxytryptamine 2C Receptor Mutant Mice”, The Journal of Neuoscience, vol. 22, No. 22, pp. 10039-10045 (Nov. 15, 2002). |
Richard B. Silverman, “Chapter 8, prodrugs and Drug Delivery Systems”, The Organic Chemistry of Drug Design and Drug Action, pp. 352-361 (1992). |
Robert E. Solomon et al., “Mechanisms of Effects of Intrathecal Serotonin on Nociception and Blood Pressure in Rats1”, The Journal of Pharmacology and Experimental Therapeutics, vol. 245, No. 3, pp. 905-912 (1988). |
William D. Steers et al., “Effects of m-chlorophenylpiperazine on penile and bladder functions in rats”, Am. J. Physiol., vol. 257, pp. R1441-R1449, (1989). |
William D. Steers et al., “Effects of Serotonergic Agonists on Micturition and Sexual Function in the Rat”, Drug Development Research, vol. 27, pp. 361-375 (1992). |
Denise M. Tomkins et al., “An investigation of the role of 5-HT2c receptors in modifying ethanol self-administration behaviour”, Pharmacology, Biochemistry and Behavior, vol. 71, pp. 735-744 (2002). |
Lee et al. Effect of the Serotonin Agonist, MK-212, on Body Temperature in Schizophrenia. Biological Psychiatry, 1992:31, pp. 460-470. |
Lumma, Jr. et al. Piperazinylpyrazines with Central Seroloninmimetric Activity. Journal of Medicinal Chemistry, 1978, vol. 21, No. 6. pp. 536-542. |
Jemrick-Luecke et al. Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212. European Journal of Pharmacology, vol. 311, 1996. pp. 217-211. |
Conn et al. Relative Efficacies of Piperazines at the Phosphoinositide Hydrolysis-Linked Serotonergic (5-HT-2 and 5-HT-1c) Receptors. The Journal of Pharmacology and Experimental Therapeutics, vol. 242, No. 2, 1987. pp. 552-557. |